342 related articles for article (PubMed ID: 28727543)
1. Non-Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications.
Zhou M; Leung A; Echegaray S; Gentles A; Shrager JB; Jensen KC; Berry GJ; Plevritis SK; Rubin DL; Napel S; Gevaert O
Radiology; 2018 Jan; 286(1):307-315. PubMed ID: 28727543
[TBL] [Abstract][Full Text] [Related]
2. Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results.
Gevaert O; Xu J; Hoang CD; Leung AN; Xu Y; Quon A; Rubin DL; Napel S; Plevritis SK
Radiology; 2012 Aug; 264(2):387-96. PubMed ID: 22723499
[TBL] [Abstract][Full Text] [Related]
3. Correlation between CT based radiomics features and gene expression data in non-small cell lung cancer.
Wang T; Gong J; Duan HH; Wang LJ; Ye XD; Nie SD
J Xray Sci Technol; 2019; 27(5):773-803. PubMed ID: 31450540
[TBL] [Abstract][Full Text] [Related]
4. Genomics of non-small cell lung cancer (NSCLC): Association between CT-based imaging features and EGFR and K-RAS mutations in 122 patients-An external validation.
Rizzo S; Raimondi S; de Jong EEC; van Elmpt W; De Piano F; Petrella F; Bagnardi V; Jochems A; Bellomi M; Dingemans AM; Lambin P
Eur J Radiol; 2019 Jan; 110():148-155. PubMed ID: 30599853
[TBL] [Abstract][Full Text] [Related]
5. Radiogenomic Analysis Demonstrates Associations between (18)F-Fluoro-2-Deoxyglucose PET, Prognosis, and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
Yamamoto S; Huang D; Du L; Korn RL; Jamshidi N; Burnette BL; Kuo MD
Radiology; 2016 Jul; 280(1):261-70. PubMed ID: 27082783
[TBL] [Abstract][Full Text] [Related]
6. CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer.
Chang SC; Lai YC; Chen YC; Wang NK; Wang WS; Lai JI
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e283-e288. PubMed ID: 29124886
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.
Wu J; Li B; Sun X; Cao G; Rubin DL; Napel S; Ikeda DM; Kurian AW; Li R
Radiology; 2017 Nov; 285(2):401-413. PubMed ID: 28708462
[TBL] [Abstract][Full Text] [Related]
8. [Hsp90AB1 Protein is Overexpressed in Non-small Cell Lung Cancer Tissues
and Associated with Poor Prognosis in Lung Adenocarcinoma Patients].
Wang M; Feng L; Li P; Han N; Gao Y; Xiao T
Zhongguo Fei Ai Za Zhi; 2016 Feb; 19(2):64-9. PubMed ID: 26903158
[TBL] [Abstract][Full Text] [Related]
9. Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC).
Hsu PC; Jablons DM; Yang CT; You L
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387256
[TBL] [Abstract][Full Text] [Related]
10. Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.
Stewart RL; West D; Wang C; Weiss HL; Gal T; Durbin EB; O'Connor W; Chen M; O'Connor KL
Hum Pathol; 2016 Aug; 54():174-83. PubMed ID: 27107458
[TBL] [Abstract][Full Text] [Related]
11. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
[TBL] [Abstract][Full Text] [Related]
12. Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.
Stewart EL; Mascaux C; Pham NA; Sakashita S; Sykes J; Kim L; Yanagawa N; Allo G; Ishizawa K; Wang D; Zhu CQ; Li M; Ng C; Liu N; Pintilie M; Martin P; John T; Jurisica I; Leighl NB; Neel BG; Waddell TK; Shepherd FA; Liu G; Tsao MS
J Clin Oncol; 2015 Aug; 33(22):2472-80. PubMed ID: 26124487
[TBL] [Abstract][Full Text] [Related]
13. Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance.
Zhang Q; Sun T; Kang P; Qian K; Deng B; Zhou J; Wang R; Jiang B; Li K; Liu F; Wu S; Tan Q
Cancer Chemother Pharmacol; 2016 Mar; 77(3):583-93. PubMed ID: 26842788
[TBL] [Abstract][Full Text] [Related]
14. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
[TBL] [Abstract][Full Text] [Related]
15. A radiogenomic dataset of non-small cell lung cancer.
Bakr S; Gevaert O; Echegaray S; Ayers K; Zhou M; Shafiq M; Zheng H; Benson JA; Zhang W; Leung ANC; Kadoch M; Hoang CD; Shrager J; Quon A; Rubin DL; Plevritis SK; Napel S
Sci Data; 2018 Oct; 5():180202. PubMed ID: 30325352
[TBL] [Abstract][Full Text] [Related]
16. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
[TBL] [Abstract][Full Text] [Related]
17. Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling.
Yeh AC; Li H; Zhu Y; Zhang J; Khramtsova G; Drukker K; Edwards A; McGregor S; Yoshimatsu T; Zheng Y; Niu Q; Abe H; Mueller J; Conzen S; Ji Y; Giger ML; Olopade OI
Cancer Imaging; 2019 Jul; 19(1):48. PubMed ID: 31307537
[TBL] [Abstract][Full Text] [Related]
18. ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization.
Yamamoto S; Korn RL; Oklu R; Migdal C; Gotway MB; Weiss GJ; Iafrate AJ; Kim DW; Kuo MD
Radiology; 2014 Aug; 272(2):568-76. PubMed ID: 24885982
[TBL] [Abstract][Full Text] [Related]
19. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
[TBL] [Abstract][Full Text] [Related]
20. Characterization of periostin isoform pattern in non-small cell lung cancer.
Morra L; Rechsteiner M; Casagrande S; von Teichman A; Schraml P; Moch H; Soltermann A
Lung Cancer; 2012 May; 76(2):183-90. PubMed ID: 22079858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
